- Home
- AREB vs SONN Comparison
AREB vs SONN Comparison
Compare AREB & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AREB
- SONN
- Stock Information
- Founded
- AREB 2014
- SONN N/A
- Country
- AREB United States
- SONN United States
- Employees
- AREB N/A
- SONN N/A
- Industry
- AREB Plastic Products
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- AREB Industrials
- SONN Health Care
- Exchange
- AREB Nasdaq
- SONN Nasdaq
- Market Cap
- AREB 5.7M
- SONN 3.8M
- IPO Year
- AREB N/A
- SONN N/A
- Fundamental
- Price
- AREB $1.40
- SONN $1.17
- Analyst Decision
- AREB
- SONN Strong Buy
- Analyst Count
- AREB 0
- SONN 1
- Target Price
- AREB N/A
- SONN $20.00
- AVG Volume (30 Days)
- AREB 2.4M
- SONN 35.4K
- Earning Date
- AREB 05-15-2025
- SONN 05-13-2025
- Dividend Yield
- AREB N/A
- SONN N/A
- EPS Growth
- AREB N/A
- SONN N/A
- EPS
- AREB N/A
- SONN N/A
- Revenue
- AREB $9,887,755.00
- SONN $1,000,000.00
- Revenue This Year
- AREB N/A
- SONN $5,376.22
- Revenue Next Year
- AREB N/A
- SONN N/A
- P/E Ratio
- AREB N/A
- SONN N/A
- Revenue Growth
- AREB N/A
- SONN 978.39
- 52 Week Low
- AREB $1.10
- SONN $1.08
- 52 Week High
- AREB $231.75
- SONN $16.00
- Technical
- Relative Strength Index (RSI)
- AREB 34.65
- SONN 41.48
- Support Level
- AREB $2.20
- SONN $1.08
- Resistance Level
- AREB $3.05
- SONN $1.21
- Average True Range (ATR)
- AREB 0.25
- SONN 0.08
- MACD
- AREB 0.07
- SONN -0.01
- Stochastic Oscillator
- AREB 1.20
- SONN 30.00
About AREB American Rebel Holdings Inc.
American Rebel Holdings Inc develops self-defense, safe storage, and patriotic product areas using a wholesale distribution network, utilizing personal appearances, musical venue performances, as well as e-commerce and television. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, jackets, coats, and Others. The Company views its operations and manages its business as one operating segment engaged in patriotic goods, comprised of safes, soft goods, and beer.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.